Trial: 202104077

A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements.

Phase

II/III

Principal Investigator

Bartlett, Nancy

Disease Site

Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov